Chk1/2 inhibitor AZD7762 enhances the susceptibility of IDH-mutant brain cancer cells to temozolomide
Articles > Article · 2022
Authors: Erkin ÖZGİRAY, fatma söğütlü, Çığır BİRAY AVCI
MEDICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, 2022, vol 39